Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)

China flag China · Delayed Price · Currency is CNY
14.58
+0.29 (2.03%)
At close: Mar 10, 2026
78.02%
Market Cap 4.22B
Revenue (ttm) 797.25M
Net Income (ttm) 25.41M
Shares Out 289.15M
EPS (ttm) 0.09
PE Ratio 167.20
Forward PE n/a
Dividend 0.10 (0.70%)
Ex-Dividend Date Jul 9, 2025
Volume 5,173,200
Average Volume 6,043,594
Open 14.32
Previous Close 14.29
Day's Range 14.30 - 14.58
52-Week Range 8.06 - 32.14
Beta 0.61
RSI 46.83
Earnings Date Apr 17, 2026

About SHE:002365

Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces ethylene oxide, polycarboxylic acid-based water reducer monomers, water reducers, and health products. The company engages in scientific research and technical service, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming. Qianjiang Yongan Pharmaceutical Co., Ltd. was founded in 2001 and is based in Qianjiang, China. [Read more]

Sector Healthcare
Founded 2001
Employees 930
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002365
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.